AAAAAA

   
Results: 1-8 |
Results: 8
Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor
Authors: Rick, O Beyer, J Schwella, N Schubart, H Schleicher, J Siegert, W
Citation: O. Rick et al., Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor, ANN ONCOL, 12(8), 2001, pp. 1151-1155
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer
Authors: Rick, O Bokemeyer, C Beyer, J Hartmann, JT Schwella, N Kingreen, D Neureither, S Metzner, B Casper, J Wandt, H Hartmann, F Schmoll, HJ Derigs, G Gerl, A Berdel, WE Kanz, L Siegert, W
Citation: O. Rick et al., Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer, J CL ONCOL, 19(1), 2001, pp. 81-88
Inverse relationship between patient peripheral blood CD34+ cell counts and collection efficiency for CD34+ cells in two automated leukapheresis systems
Authors: Heuft, HG Dubiel, M Rick, O Kingreen, D Serke, S Schwella, N
Citation: Hg. Heuft et al., Inverse relationship between patient peripheral blood CD34+ cell counts and collection efficiency for CD34+ cells in two automated leukapheresis systems, TRANSFUSION, 41(8), 2001, pp. 1008-1013
PBPC mobilization with paclitaxel, ifosfamide, and G-CSF with or without amifostine: results of a prospective randomized trial
Authors: Rick, O Schwella, N Beyer, J Dubiel, M Krusch, A Hildebrandt, M Schleicher, J Serke, S Siegert, W
Citation: O. Rick et al., PBPC mobilization with paclitaxel, ifosfamide, and G-CSF with or without amifostine: results of a prospective randomized trial, TRANSFUSION, 41(2), 2001, pp. 196-200
Successful autologous bone marrow rescue in patients who failed peripheralblood stem cell mobilization
Authors: Rick, O Beyer, J Kingreen, D Kuhl, JS Zingsem, J Huhn, D Siegert, W Schwella, N
Citation: O. Rick et al., Successful autologous bone marrow rescue in patients who failed peripheralblood stem cell mobilization, ANN HEMATOL, 79(12), 2000, pp. 681-686
Automated collection of peripheral blood stem cells with the COBE spectra for autotransplantation
Authors: Heuft, HG Dubiel, M Kingreen, D Oertel, J De Reys, S Rick, O Serke, S Schwella, N
Citation: Hg. Heuft et al., Automated collection of peripheral blood stem cells with the COBE spectra for autotransplantation, VOX SANGUIN, 79(2), 2000, pp. 94-99
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma
Authors: Schmidt-Wolf, IGH Finke, S Trojaneck, B Denkena, A Lefterova, P Schwella, N Heuft, HG Prange, G Korte, M Takeya, M Dorbic, T Neubauer, A Wittig, B Huhn, D
Citation: Igh. Schmidt-wolf et al., Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma, BR J CANC, 81(6), 1999, pp. 1009-1016
High-dose chemotherapy in germ cell tumours: a large single centre experience
Authors: Rick, O Beyer, J Kingreen, D Schwella, N Krusch, A Schleicher, J Kirsch, A Huhn, D Siegert, W
Citation: O. Rick et al., High-dose chemotherapy in germ cell tumours: a large single centre experience, EUR J CANC, 34(12), 1998, pp. 1883-1888
Risultati: 1-8 |